Heron Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	28.65	25.8	28.68	15.36	90.54
Short-Term Investments	17.98	33.48	51.73	69.49	67.04
Cash & Short-Term Investments	46.63	59.28	80.41	84.85	157.58
Cash Growth	-21.34%	-26.27%	-5.24%	-46.15%	-24.42%
Receivables	89.59	78.88	60.14	52.05	35.5
Inventory	92.75	53.16	42.11	54.57	48.38
Prepaid Expenses	9.1	17.69	6.12	13.96	12.96
Total Current Assets	238.07	209.01	188.77	205.44	254.42
Property, Plant & Equipment	12.4	17.65	25.6	29.81	33.56
Other Long-Term Assets	5.41	6.48	8.13	15.71	17.72
Total Assets	255.88	233.15	222.51	250.95	305.71
Accounts Payable	8.99	11.71	3.24	3.23	3.8
Accrued Expenses	87.1	76.71	73.37	76.44	62.26
Current Portion of Leases	-	3.04	3.08	2.69	2.42
Other Current Liabilities	-	-	-	-	2.58
Total Current Liabilities	96.1	91.46	79.69	82.36	71.06
Long-Term Debt	140.64	174.73	173.75	149.28	149.08
Long-Term Leases	-	-	2.8	5.5	8
Other Long-Term Liabilities	4.81	0.62	0.24	0.24	-
Total Liabilities	241.54	266.8	256.48	237.38	228.14
Common Stock	1.88	1.52	1.5	1.19	1.02
Additional Paid-In Capital	1,951	1,884	1,871	1,808	1,690
Retained Earnings	-1,940	-1,920	-1,906	-1,795	-1,613
Comprehensive Income & Other	0	0.01	0.01	-0.02	-0.01
Total Common Equity	13.28	-33.65	-33.97	13.57	77.57
Shareholders' Equity	14.33	-33.65	-33.97	13.57	77.57
Total Liabilities & Equity	255.88	233.15	222.51	250.95	305.71
Total Debt	140.64	177.76	179.63	157.48	159.5
Net Cash (Debt)	-94.01	-118.48	-99.22	-72.63	-1.92
Net Cash Per Share	-0.56	-0.78	-0.72	-0.67	-0.02
Filing Date Shares Outstanding	188.31	152.33	150.33	119.26	102.14
Total Common Shares Outstanding	188.31	152.13	150.29	119.16	102.01
Working Capital	141.97	117.56	109.09	123.08	183.37
Book Value Per Share	0.07	-0.22	-0.23	0.11	0.76
Tangible Book Value	13.28	-33.65	-33.97	13.57	77.57
Tangible Book Value Per Share	0.07	-0.22	-0.23	0.11	0.76
Machinery	-	32.4	36.55	35.81	36.37
Leasehold Improvements	-	0.31	0.65	0.65	0.61

Updated Feb 26, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q